Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group

Author(s):: Joris, M.M.; Bierings, M.B.; Egeler, R.M.; Claas, F.H.J. (0000-0003-4157-6201); Rood, J.J. van; Oudshoorn, M.

Published: 2012
Publication type: Article / Letter to editor

allogeneichematopoietic SCTaccess

Date issued: 2012-05-31
Language: English
Is part of: Bone Marrow Transplantation (2012), Vol. 47, no. 5, p. 677-683
hdl: 1887/107432
doi: 10.1038/bmt.2011.168